Topic:

R&D

Latest Headlines

Latest Headlines

Bayer's Nexavar misses another study endpoint, this time for breast cancer

Nexavar, the blockbuster cancer drug sold by Bayer and Onyx Pharmaceuticals, has failed again in a trial for a new indication. 

Mayo Clinic, Enterprise Ireland partner to advance med tech

An interesting development in this age of Irish-fueled tax inversion deals, the  Mayo Clinic  and Enterprise Ireland have begun a 5-year collaboration to advance med tech innovation.

Keryx touts its kidney drug with an FDA decision around the corner

Keryx Biopharmaceuticals' in-development Zerenex helped reduce dangerous buildups of phosphorus in patients on kidney dialysis, meeting its goals in a Phase III study as the company awaits final word from the FDA.

Nanoparticles point to cancerous tumors in MRIs

Researchers are hoping to get into the clinic in the next three to 5 years with a self-assembling nanoparticle that targets tumors. The idea behind the technology is to make cancer cells more identifiable when using magnetic resonance imaging screening.

Most absorbent material on Earth gives poorly soluble drugs a boost

A record-breaking material discovered last year by Swedish researchers has passed another milestone for drug delivery, showing it can hold poorly soluble drugs and, down the road, deliver them with a fast dissolution rate.

Device to create human platelets could transform transfusion

A platelet bioreactor was developed by researchers at Brigham and Women's Hospital.

Broad Institute set to swell psychiatric databases using $650M gift

The psychiatric sector received a big boost this week when the Broad Institute was given $650 million to investigate the genetic causes of mental illnesses such as schizophrenia and bipolar disorder. And the impact of the work is set to extend far beyond Cambridge, with Broad making the data available to researchers around the world.

Study: Red tape hindering use of EHRs in research

The rise of electronic health records was heralded as a step toward the merging of patient care and research, a scenario in which data from the day-to-day of healthcare is gathered to inform treatment and drug development. But a study in the United Kingdom suggests that while technology can now facilitate this vision, the path is blocked by another barrier: red tape.

NeuroPace stimulator to be deployed in $40M DOD brain research initiative

The $40 million Department of Defense research program into restoring memory will use NeuroPace's implantable neurostimulator, a move that the company said could help it expand the product's indications beyond epilepsy.

Tuberculosis cocktail stirs hopes for quick cures in patients with HIV

A new three-drug combo treatment for tuberculosis better eradicated the disease than standard therapy in a midstage trial, showing particular promise for patients with HIV as it rolls into Phase III development.